These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 31877303)
1. miR-200b/c-RAP1B axis represses tumorigenesis and malignant progression of papillary thyroid carcinoma through inhibiting the NF-κB/Twist1 pathway. Zhou B; Xu J; Chen Y; Gao S; Feng X; Lu X Exp Cell Res; 2020 Feb; 387(2):111785. PubMed ID: 31877303 [TBL] [Abstract][Full Text] [Related]
2. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression. Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202 [TBL] [Abstract][Full Text] [Related]
3. KPNA4 regulated by miR-548b-3p promotes the malignant phenotypes of papillary thyroid cancer. Feng L; Wang R; Yang Y; Shen X; Shi Q; Lian M; Ma H; Fang J Life Sci; 2021 Jan; 265():118743. PubMed ID: 33188837 [TBL] [Abstract][Full Text] [Related]
4. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer. Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p. Chen Y; Li Y; Gao H Cancer Med; 2020 Mar; 9(5):1830-1841. PubMed ID: 31943867 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer. Gao H; Sun X; Wang H; Zheng Y Cell Cycle; 2020 May; 19(10):1186-1199. PubMed ID: 32306838 [TBL] [Abstract][Full Text] [Related]
7. The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis. Sui G; Zhang B; Fei D; Wang H; Guo F; Luo Q J Cell Physiol; 2020 Oct; 235(10):6615-6624. PubMed ID: 32048306 [TBL] [Abstract][Full Text] [Related]
8. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma. Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126 [TBL] [Abstract][Full Text] [Related]
9. microRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2-depentent Notch signaling pathway. Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J J Cell Physiol; 2020 Mar; 235(3):2492-2505. PubMed ID: 31565805 [TBL] [Abstract][Full Text] [Related]
10. Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212. Wang R; Zhao L; Ji L; Bai L; Wen Q Biomed Pharmacother; 2019 Oct; 118():109298. PubMed ID: 31404776 [TBL] [Abstract][Full Text] [Related]
11. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor. Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537 [TBL] [Abstract][Full Text] [Related]
12. Circ_PSD3 promotes the progression of papillary thyroid carcinoma via the miR-637/HEMGN axis. Li Z; Huang X; Liu A; Xu J; Lai J; Guan H; Ma J Life Sci; 2021 Jan; 264():118622. PubMed ID: 33203523 [TBL] [Abstract][Full Text] [Related]
13. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67. Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096 [TBL] [Abstract][Full Text] [Related]
14. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p. Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression. Sun Y; Shi T; Ma Y; Qin H; Li K Cell Cycle; 2020 Apr; 19(7):787-800. PubMed ID: 32075502 [TBL] [Abstract][Full Text] [Related]
16. CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways. Li C; Zhu L; Fu L; Han M; Li Y; Meng Z; Qiu X Diagn Pathol; 2021 Oct; 16(1):93. PubMed ID: 34689819 [TBL] [Abstract][Full Text] [Related]
17. TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells. Orlandella FM; Di Maro G; Ugolini C; Basolo F; Salvatore G Oncotarget; 2016 Oct; 7(43):70575-70588. PubMed ID: 27661106 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway. Wu YC; Li SY; Jia YF Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8940-8949. PubMed ID: 31696481 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development. Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043 [TBL] [Abstract][Full Text] [Related]
20. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway. Ma Y; Qin H; Cui Y Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]